Assessing apical heart rate before each digoxin dose is the priority to prevent life-threatening bradycardia or arrhythmias from toxicity. Other interventions like monitoring weight, oxygen therapy, or positioning are important but less time-critical.
심화 해설
Understanding the Clinical Context
This question centers on the safe administration of digoxin to a 6-month-old infant with hypoplastic left heart syndrome (HLHS) who is exhibiting signs of heart failure. HLHS is a critical congenital heart defect where the left side of the heart is underdeveloped, making the right ventricle responsible for pumping blood to both the pulmonary and systemic circulations. In this delicate balance, the infant is highly susceptible to heart failure. Digoxin is a cardiac glycoside used to improve myocardial contractility, but it has a narrow therapeutic index, especially in infants. The priority nursing intervention is the one that directly prevents a life-threatening adverse drug event.
Analysis of the Correct Answer (Option 4)
The correct action is to assess the apical heart rate before each digoxin dose. Digoxin’s primary mechanism involves inhibiting the sodium-potassium ATPase pump, a fundamental membrane transport protein. This inhibition increases intracellular sodium, which in turn reduces the activity of the sodium-calcium exchanger, leading to an increase in intracellular calcium and thus stronger cardiac contractility . However, digoxin also enhances vagal tone on the sinoatrial (SA) and atrioventricular (AV) nodes, which can cause significant bradycardia and progressive heart block, the earliest and most common signs of digoxin toxicity in pediatric patients.
The standard NCLEX-RN safety protocol mandates holding digoxin if the infant’s apical pulse is below 90-110 bpm (depending on institutional policy for infants). Administering the drug when the heart rate is already dangerously low can precipitate complete heart block or asystole. This is a direct, immediate safety check that must precede every dose, making it the absolute priority over ongoing monitoring or comfort measures.
Why Other Options Are Not the Priority
- Option 1: Monitor daily weight and strict intake and output measurements. While essential for evaluating fluid balance and the effectiveness of heart failure therapy, this is an ongoing assessment. It does not provide the immediate, pre-administration safety data needed to prevent a potentially fatal medication error. A change in daily weight reflects a trend over 24 hours, not a moment-to-moment risk of toxicity.
- Option 2: Administer oxygen therapy to maintain oxygen saturation above 95%. This is a potentially harmful intervention in HLHS. The infant’s systemic and pulmonary circulations are balanced through a delicate ratio of vascular resistance. High oxygen concentrations act as a pulmonary vasodilator, which can dangerously increase pulmonary blood flow at the expense of systemic perfusion, leading to circulatory collapse and worsening acidosis. The therapeutic goal is typically to maintain oxygen saturations between 75% and 85% to ensure a balanced circulation. This option reflects a critical misunderstanding of single-ventricle physiology.
- Option 3: Position the infant in semi-Fowler's position to reduce cardiac workload. Positioning is a comfort and supportive measure that can help reduce venous return and preload. However, it is not a safety-critical intervention that must be performed immediately before a medication is given. The risk of administering digoxin to a bradycardic infant is a more immediate threat to life than the positioning-related benefit to cardiac workload.
Deep Dive into the Pathophysiology and Safety Rationale
The priority logic is rooted in the fundamental structure of the nursing process and medication safety. Assessment must precede intervention. Before you administer a dose of a high-alert medication like digoxin, you must assess the parameter that defines its safety threshold. The function of the sodium-potassium ATPase pump, a key member of the SLC-ome of membrane transporters, is central to this . Digoxin’s direct blockade of this pump is what provides its therapeutic effect, but excessive blockade leads to toxicity, manifesting first as a dangerously slow heart rate. In the context of an already compromised heart in HLHS, a toxic bradycardia is poorly tolerated and can quickly become fatal. Therefore, the apical pulse check is the single most critical, non-negotiable nursing action that directly prevents a catastrophic outcome from the very treatment intended to help the infant.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.